New Zealand markets open in 5 hours 39 minutes

MEI Pharma, Inc. (MEIP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9100-0.0400 (-1.36%)
At close: 04:00PM EDT
2.9600 +0.05 (+1.72%)
After hours: 04:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 19.39M
Enterprise value -25.50M
Trailing P/E 0.74
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.29
Price/book (mrq)0.38
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3-56.17%
S&P500 52-week change 322.55%
52-week high 37.8700
52-week low 32.7300
50-day moving average 33.0156
200-day moving average 34.8817

Share statistics

Avg vol (3-month) 318.42k
Avg vol (10-day) 311.05k
Shares outstanding 56.66M
Implied shares outstanding 66.66M
Float 84.93M
% held by insiders 10.70%
% held by institutions 143.33%
Shares short (14 Jun 2024) 414.5k
Short ratio (14 Jun 2024) 40.59
Short % of float (14 Jun 2024) 40.26%
Short % of shares outstanding (14 Jun 2024) 40.22%
Shares short (prior month 15 May 2024) 430.47k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Dec 2023
Ex-dividend date 416 Nov 2023
Last split factor 21:20
Last split date 317 Apr 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 39.18%
Operating margin (ttm)30.53%

Management effectiveness

Return on assets (ttm)12.40%
Return on equity (ttm)61.26%

Income statement

Revenue (ttm)66.75M
Revenue per share (ttm)10.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 20.73M
Net income avi to common (ttm)26.16M
Diluted EPS (ttm)3.9200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)56.55M
Total cash per share (mrq)8.49
Total debt (mrq)11.67M
Total debt/equity (mrq)22.86%
Current ratio (mrq)6.17
Book value per share (mrq)7.66

Cash flow statement

Operating cash flow (ttm)-43.78M
Levered free cash flow (ttm)7.19M